General Information of Drug Off-Target (DOT) (ID: OTDT0XZK)

DOT Name Apoptosis regulatory protein Siva (SIVA1)
Synonyms CD27-binding protein; CD27BP
Gene Name SIVA1
Related Disease
Carcinoma of liver and intrahepatic biliary tract ( )
Liver cancer ( )
Pneumonia ( )
Colon cancer ( )
Colon carcinoma ( )
Coxsackie virus infection ( )
Lung adenocarcinoma ( )
Neoplasm ( )
Nasopharyngeal carcinoma ( )
Retinopathy ( )
Advanced cancer ( )
Bone osteosarcoma ( )
Hepatocellular carcinoma ( )
Non-small-cell lung cancer ( )
Osteosarcoma ( )
UniProt ID
SIVA_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF05458
Sequence
MPKRSCPFADVAPLQLKVRVSQRELSRGVCAERYSQEVFEKTKRLLFLGAQAYLDHVWDE
GCAVVHLPESPKPGPTGAPRAARGQMLIGPDGRLIRSLGQASEADPSGVASIACSSCVRA
VDGKAVCGQCERALCGQCVRTCWGCGSVACTLCGLVDCSDMYEKVLCTSCAMFET
Function Induces CD27-mediated apoptosis. Inhibits BCL2L1 isoform Bcl-x(L) anti-apoptotic activity. Inhibits activation of NF-kappa-B and promotes T-cell receptor-mediated apoptosis.
Tissue Specificity Ubiquitous. Mostly expressed in thymus, testis, ovary, prostate, small intestine and spleen and less in colon.
KEGG Pathway
p53 sig.ling pathway (hsa04115 )

Molecular Interaction Atlas (MIA) of This DOT

15 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Carcinoma of liver and intrahepatic biliary tract DIS8WA0W Definitive Altered Expression [1]
Liver cancer DISDE4BI Definitive Altered Expression [1]
Pneumonia DIS8EF3M Definitive Altered Expression [2]
Colon cancer DISVC52G Strong Altered Expression [3]
Colon carcinoma DISJYKUO Strong Altered Expression [3]
Coxsackie virus infection DISY1VPA Strong Biomarker [4]
Lung adenocarcinoma DISD51WR Strong Genetic Variation [5]
Neoplasm DISZKGEW Strong Biomarker [6]
Nasopharyngeal carcinoma DISAOTQ0 moderate Biomarker [7]
Retinopathy DISB4B0F moderate Biomarker [8]
Advanced cancer DISAT1Z9 Limited Biomarker [6]
Bone osteosarcoma DIST1004 Limited Biomarker [9]
Hepatocellular carcinoma DIS0J828 Limited Biomarker [10]
Non-small-cell lung cancer DIS5Y6R9 Limited Biomarker [6]
Osteosarcoma DISLQ7E2 Limited Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
19 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Apoptosis regulatory protein Siva (SIVA1). [11]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [12]
Acetaminophen DMUIE76 Approved Acetaminophen affects the expression of Apoptosis regulatory protein Siva (SIVA1). [13]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [14]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Apoptosis regulatory protein Siva (SIVA1). [15]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [17]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [17]
Phenobarbital DMXZOCG Approved Phenobarbital affects the expression of Apoptosis regulatory protein Siva (SIVA1). [18]
Cannabidiol DM0659E Approved Cannabidiol decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [19]
Bortezomib DMNO38U Approved Bortezomib decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [20]
Nicotine DMWX5CO Approved Nicotine decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [21]
Piroxicam DMTK234 Approved Piroxicam decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [22]
Cidofovir DMA13GD Approved Cidofovir increases the expression of Apoptosis regulatory protein Siva (SIVA1). [15]
Ifosfamide DMCT3I8 Approved Ifosfamide increases the expression of Apoptosis regulatory protein Siva (SIVA1). [15]
Clodronate DM9Y6X7 Approved Clodronate increases the expression of Apoptosis regulatory protein Siva (SIVA1). [15]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [23]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [24]
Bisphenol A DM2ZLD7 Investigative Bisphenol A affects the expression of Apoptosis regulatory protein Siva (SIVA1). [25]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Apoptosis regulatory protein Siva (SIVA1). [26]
------------------------------------------------------------------------------------
⏷ Show the Full List of 19 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic increases the methylation of Apoptosis regulatory protein Siva (SIVA1). [16]
------------------------------------------------------------------------------------

References

1 Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.Drug Des Devel Ther. 2019 Apr 23;13:1289-1300. doi: 10.2147/DDDT.S200610. eCollection 2019.
2 Scheduled Intravenous Acetaminophen for Postoperative Management of Patients Who Had Thoracoscopic Esophagectomy for Esophageal Cancer.Anticancer Res. 2019 Jan;39(1):467-470. doi: 10.21873/anticanres.13135.
3 Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.Apoptosis. 2011 Jan;16(1):35-44. doi: 10.1007/s10495-010-0538-0.
4 The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22.Mol Cell Biochem. 2006 Jul;287(1-2):147-55. doi: 10.1007/s11010-005-9082-6. Epub 2006 May 9.
5 Adenylosuccinate synthetase 1 gene is a novel target of deletion in lung adenocarcinoma.Mol Carcinog. 2009 Dec;48(12):1116-22. doi: 10.1002/mc.20563.
6 Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene.Onco Targets Ther. 2018 Oct 1;11:6361-6367. doi: 10.2147/OTT.S173001. eCollection 2018.
7 Anticancer activity of recombinant Siva1 protein in human nasopharyngeal carcinoma cell line CNE-2.Cancer Biomark. 2015;15(6):833-41. doi: 10.3233/CBM-150527.
8 Retinal Vascular Imaging Markers and Incident Chronic Kidney Disease: A Prospective Cohort Study.Sci Rep. 2017 Aug 24;7(1):9374. doi: 10.1038/s41598-017-09204-2.
9 Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells.Oncol Lett. 2017 Aug;14(2):1512-1518. doi: 10.3892/ol.2017.6307. Epub 2017 Jun 2.
10 Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma.Onco Targets Ther. 2019 Mar 28;12:2373-2381. doi: 10.2147/OTT.S188658. eCollection 2019.
11 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
12 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
13 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
14 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
15 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
16 Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011 Feb 18;24(2):165-7. doi: 10.1021/tx1004419. Epub 2011 Feb 4.
17 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
18 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
19 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
20 Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Leuk Res. 2008 Feb;32(2):275-85. doi: 10.1016/j.leukres.2007.05.024. Epub 2007 Jul 19.
21 Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 2006 Oct 20;1116(1):39-49.
22 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
23 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
24 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
25 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
26 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.